NewsView printer-friendly version
Coherus Management to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
The audio portion of the presentation will be available on the investors’ page of the
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system. Coherus’ strategy is to build a leading immuno-oncology franchise funded with cash generated by its commercial biosimilar business. For additional information, please visit www.coherus.com.
Coherus Contact Information:
+1 (650) 395-0152
+1 (949) 903-4750
Source: Coherus BioSciences, Inc.